Catalogo dei prodotti della ricerca

IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.

Objective. Uterine myomas represent the most common benign gynecological tumors and about 40-60% of patients with fibroids are asymptomatic. The diagnosis is often incidental and the treatment depends on patient's age, size of fibroids, estimated rate of growth, woman's fertility plans and risk of malignancy. Despite the prevalence, scientific research regarding asymptomatic fibroids is still underfunded compared with other nonmalignant diseases and actually, no guidelines are reported about management and treatment of themselves. Material and method We conducted a review of literature from February to May 2017. PubMed (MEDLINE), Web of Science databases, EMBASE, Cochrane Library and Scopus database were systematically searched for records reporting on asymptomatic fibroids. Results. Further large studies are needed to define the management of asymptomatic fibroids, real indications to treatment and risks and benefits of a waiting strategy when no treatment is needed can be drawn. Conclusion. No standard guidelines for the management of asymptomatic fibroids have been reported. Treatment is individualized and depends on patient s age, size of fibroids, woman s fertility plans and risk of malignancy.

Uterine asymptomatic myomas: An overview from diagnosis to treatment / Di Donato, V.; Musella, A.; Bracchi, C.; Lecce, F.; Colagiovanni, V.; Di Pinto, A.; Santangelo, G.; Giannini, A.; Tomao, F.; Palaia, I.; Perniola, G.; Muzii, L.; Benedetti Panici, P.. - In: GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA. - ISSN 0391-9013. - 41:2(2019), pp. 76-83.

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2022